Transcription of Early Treatment of COVID-19 with Repurposed Therapies: The ...
{{id}} {{{paragraph}}}
Clinical trialsEarly Treatment of COVID-19 with Repurposed Therapies: The TOGETHER Adaptive Platform TrialBuilding Platform Trial Infrastructure for Infectious trialsCo-Principal InvestigatorsDr. Edward MillsProfessorHealth Research Methods, Evidence, and ImpactMcMaster University Dr. GilmarReisAssociate ProfessorDivision of MedicinePontificia UniversidadeCat licade Minas GeraisClinical trialsSenior InvestigatorsDr. Craig RaynerAssociate ProfessorMonash UniversityPresident, Integrated Drug DevelopmentCertara Angela ReiersenAssociate ProfessorDepartment of Psychiatry, Washington University in St.
Patients over the age of 18 2. Presenting to an outpatient care setting with an acute clinical condition consistent with COVID-19 and symptoms beginning within 7 days of the ... adhere to the procedures proposed in the protocol 19. Known hypersensitivity and / or intolerance to fluvoxamine, ivermectin
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}